Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Direct Eyebrow Lift Scars
NCT06465056Phase 2Recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in surgical scar, sponsored by Universidade de São Paulo. Started Jan 2024; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
surgical scar
Beyond the preview
Go deeper on NCT06465056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06465056.